tiprankstipranks
Trending News
More News >
Shandong Xinhua Pharmaceutical Company Limited Class H (HK:0719)
:0719
Hong Kong Market

Shandong Xinhua Pharmaceutical Company Limited Class H (0719) Income Statement

Compare
2 Followers

Shandong Xinhua Pharmaceutical Company Limited Class H Income Statement

Last quarter (Q3 2025), Shandong Xinhua Pharmaceutical Company Limited Class H's total revenue was ¥2.32B, an increase of 15.93% from the same quarter last year. In Q3, Shandong Xinhua Pharmaceutical Company Limited Class H's net income was ¥35.47M. See Shandong Xinhua Pharmaceutical Company Limited Class H’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 24Dec 23Dec 22Dec 21Dec 20
Total Revenue
¥ 8.47B¥ 8.10B¥ 7.50B¥ 6.56B¥ 6.01B
Gross Profit
¥ 2.04B¥ 2.32B¥ 2.04B¥ 1.77B¥ 1.81B
Operating Expenses
¥ 1.51B¥ 1.79B¥ 1.49B¥ 1.27B¥ 1.27B
Depreciation and Amortization
¥ 540.95M¥ 516.94M¥ 484.81M¥ 434.33M¥ 381.39M
EBITDA
¥ 1.11B¥ 1.09B¥ 1.01B¥ 908.67M¥ 856.79M
Operating Income
¥ 534.37M¥ 534.58M¥ 476.71M¥ 425.59M¥ 422.49M
Other Income/Expenses
¥ -717.25K¥ -1.90M¥ -4.93M¥ -4.36M¥ -10.85M
Pretax Income
¥ 533.65M¥ 532.69M¥ 471.77M¥ 421.23M¥ 411.64M
Net Income
¥ 470.02M¥ 496.51M¥ 411.06M¥ 348.55M¥ 324.86M
Per Share Metrics
Basic EPS
¥ 0.69¥ 0.72¥ 0.62¥ 0.56¥ 0.52
Diluted EPS
¥ 0.69¥ 0.72¥ 0.61¥ 0.56¥ 0.52
Weighted Average Shares Outstanding
682.41M 689.60M 663.22M 622.41M 621.86M
Weighted Average Shares Outstanding (Diluted)
682.41M 691.95M 674.09M 622.41M 624.73M
Currency in CNY

Shandong Xinhua Pharmaceutical Company Limited Class H Earnings and Revenue History